Labcorp Holdings Inc.
LH
$270.49
$0.110.04%
NYSE
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Revenue | 13.48B | 13.18B | 13.01B | 12.71B | 12.49B |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 13.48B | 13.18B | 13.01B | 12.71B | 12.49B |
| Cost of Revenue | 9.69B | 9.50B | 9.38B | 9.16B | 8.99B |
| Gross Profit | 3.79B | 3.68B | 3.62B | 3.55B | 3.50B |
| SG&A Expenses | 2.29B | 2.27B | 2.23B | 2.18B | 2.14B |
| Depreciation & Amortization | 272.00M | 265.90M | 256.40M | 245.20M | 237.20M |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 12.25B | 12.04B | 11.87B | 11.59B | 11.36B |
| Operating Income | 1.23B | 1.14B | 1.14B | 1.13B | 1.12B |
| Income Before Tax | 974.30M | 937.30M | 959.50M | 628.60M | 656.70M |
| Income Tax Expenses | 209.80M | 205.50M | 212.40M | 191.90M | 206.00M |
| Earnings from Continuing Operations | 764.50 | 731.80 | 747.10 | 436.70 | 450.70 |
| Earnings from Discontinued Operations | -- | -- | -- | 0.00 | 0.00 |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -1.10M | -1.00M | -1.10M | -1.20M | -1.20M |
| Net Income | 763.40M | 730.80M | 746.00M | 435.50M | 449.50M |
| EBIT | 1.23B | 1.14B | 1.14B | 1.13B | 1.12B |
| EBITDA | 1.82B | 1.72B | 1.70B | 1.68B | 1.66B |
| EPS Basic | 9.13 | 8.72 | 8.88 | 5.20 | 5.30 |
| Normalized Basic EPS | 8.18 | 7.72 | 7.84 | 7.92 | 8.00 |
| EPS Diluted | 9.07 | 8.66 | 8.83 | 5.15 | 5.26 |
| Normalized Diluted EPS | 8.12 | 7.67 | 7.80 | 7.89 | 7.97 |
| Average Basic Shares Outstanding | 334.60M | 335.30M | 335.80M | 337.10M | 339.70M |
| Average Diluted Shares Outstanding | 336.80M | 337.20M | 337.60M | 338.30M | 340.90M |
| Dividend Per Share | 2.88 | 2.88 | 2.88 | 2.88 | 2.88 |
| Payout Ratio | 31.71% | 33.20% | 32.59% | 56.05% | 55.06% |